The War on Aspirin Has Begun After Research Shows the Pill Could Threaten the Vaccine Narrative

The War on Aspirin Has Begun After Research Shows the Pill Could Threaten the Vaccine Narrative

Before ink was even dry on publication of research showing positive outcomes for patients with COVID who took aspirin, the war against the popular drug began. The little white pill used by millions is now under attack because it threatens the fear-mongering vaccine narrative.

On Tuesday reported on research that found an “association between low-dose aspirin and decreased severity of COVID-19 and death.” We reported on two significant research findings.

The first was by a team at the George Washington University in Washington, D.C., which found evidence supporting findings of a preliminary trial by Israeli researchers in March of this year.

“Now, major media outlets are going on the offensive against aspirin in an attempt to dissuade people from using it for heart attack prevention” writes RedState. The Hill released an article the same day as the findings from the George Washington University research was released. How convenient.

The Hill’s article perfectly demonstrates the new war on aspirin reporting, “An influential U.S. panel of experts changed its recommendations for people who take low dosages of aspirin in order to prevent first heart attacks or strokes.”

George Washington University investigated over 400 COVID patients hospitalized across the United States and found those who took aspirin, for reasons unrelated to their COVID virus, reduced the risk of “several parameters by almost half: reaching mechanical ventilation by 44%; ICU admissions by 43%, and overall in-hospital mortality by 47%.”

The Israeli conducted medical trial in March found, “in addition to its effect on blood clots…aspirin carried out immunological benefits” and the group taking aspirin “was 29% less likely to become infected with the virus in the first place.”

Despite the impressive and uplifting findings in support of the cost-effective and easy to acquire drug aspirin, The Hill continued:

The U.S. Preventative Services Task Force in a draft proposal released Tuesday recommended that adults ages 40 to 59 should only be taking low dosages of the blood thinner if their physician determines that they are at high risk for cardiovascular disease. 

Aspirin acts as an anticoagulant, which means it aids in preventing blood clots from forming, which is how heart attacks and strokes typically develop. Taking daily doses of aspirin was thought to lower the risk of these clots, and therefore lower the risk of heart disease and strokes. 

In addition, the new guidance detailed in the draft recommends that people over the age of 60 not take aspirin to prevent first heart attacks or strokes.


Join the Newsletter